JANX - Janux Therapeutics, Inc.

QQQ $ 610.29 $ -0.16 (-0.03 %)

DIA $ 469.10 $ 2.20 (0.47 %)

SPY $ 670.98 $ -0.01 (0 %)

TLT $ 91.99 $ 0.45 (0.49 %)

GLD $ 376.61 $ -25.91 (-6.43 %)

Previous Close

$ 26.83

Open

$ 26.80

Bid

$ 25.10 x 40

Ask

$ 27.68 x 1

Day's Range

$ 26.00 - $ 27.60

52 Week Range

$ 21.73 - $ 71.71

Volume

682,750

Average Volume

Market Cap

1.61B

Beta (5Y Monthly)

$ 1.94

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	03-08-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-10-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-18-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barclays Initiates Coverage On Janux Thera...
09/17/2025 10:51:07

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Overweight rating and announces ...

Truist Securities Initiates Coverage On Ja...
09/10/2025 13:19:21

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and ...

Stifel Reinstates Buy on Janux Therapeutic...
09/10/2025 12:32:25

Stifel analyst Bradley Canino reinstates Janux Therapeutics (NASDAQ:JANX) with a Buy and announces $45 price target.

Guggenheim Initiates Coverage On Janux The...
09/04/2025 14:01:45

Guggenheim analyst Brad Canino initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price ...

Piper Sandler Initiates Coverage On Janux ...
08/19/2025 12:14:30

Piper Sandler analyst Kelsey Goodwin initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Overweight rating and ann...

Janux Therapeutics Q2 EPS $(0.55) Misses $...
08/07/2025 20:46:59

Janux Therapeutics Announces The Dosing Of...
08/05/2025 20:44:54

Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel...

Janux Therapeutics Showcases Advancements ...
07/24/2025 20:28:01

PSMA-TRACIr designed to be combined with potentially best-in-treatment asset, JANX007, and provide CD28 co-stimulation to furth...

10 Health Care Stocks Whale Activity In To...
07/15/2025 17:35:24

this-harrow-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

This Harrow Analyst Begins Coverage On A B...
07/11/2025 16:01:42

Raymond James Initiates Coverage On Janux ...
07/11/2025 13:03:20

Raymond James analyst Sean McCutcheon initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Outperform rating and an...

Janux Therapeutics Q1 EPS $(0.38) Beats $(...
05/08/2025 20:15:37

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(...

Janux Therapeutics Initiates Phase 1b Expa...
05/05/2025 12:37:36

Phase 1b expansion study initiated in taxane-naïve mCRPC patientsUpdated data from Phase 1a dose escalation support initiation ...

HC Wainwright & Co. Reiterates Buy on Janu...
03/03/2025 11:48:23

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Janux Therapeutics (NASDAQ:JANX) with a Buy and maintains ...

Scotiabank Maintains Sector Perform on Jan...
02/28/2025 23:36:38

Scotiabank analyst George Farmer maintains Janux Therapeutics (NASDAQ:JANX) with a Sector Perform and lowers the price targe...

Janux Therapeutics Q4 2024 GAAP EPS $(0.36...
02/27/2025 21:34:25

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(...

Navigating 10 Analyst Ratings For Janux Th...
12/11/2024 20:01:05

Cantor Fitzgerald Reiterates Overweight on...
12/11/2024 16:27:55

Cantor Fitzgerald analyst Josh Schimmer reiterates Janux Therapeutics (NASDAQ:JANX) with a Overweight and maintains $200 pri...

soundhound-asana-and-victorias-secret-are-among-top-10-mid-cap-gainers-last-week-dec-2-dec-6-are-the-others-in-your-portfolio

SoundHound, Asana And Victorias Secret Are...
12/08/2024 15:15:17

Top performing mid-cap stocks last week: NBIS, SOUN, BTDR, ASAN, JANX, NVCR, KC, VSCO, ZETA, FIVE. Analysts raise price forecas...

Reported Earlier, Janux Therapeutics Price...
12/05/2024 06:26:21

The Company intends to use the net proceeds from the offering to advance clinical development of its internal product pipeline ...